Sanofi (SNY) Income from Non-Controlling Interests (2009 - 2026)

Sanofi has reported Income from Non-Controlling Interests for 18 years, with the latest figure at $39.5 million in Q2 2026.

• Quarterly Income from Non-Controlling Interests rose 172.74% year-over-year to $39.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $122.4 million (up 884.65% YoY) and the FY2025 annual result came in at $44.2 million, down 28.63% from the prior year.
• Income from Non-Controlling Interests advanced to $39.5 million in Q2 2026 per SNY's latest filing, from $7.0 million in the prior quarter.
• Over five years, Income from Non-Controlling Interests peaked at $115.3 million in Q4 2022 and troughed at -$82.2 million in Q2 2022.
• A 5-year average of $10.7 million and a median of $13.6 million in 2023 frame the typical range for Income from Non-Controlling Interests.
• The sharpest annual moves came in 2022 and 2024: Income from Non-Controlling Interests tumbled 952.83% in 2022, then soared 497.27% in 2024.
• Over 5 years, Income from Non-Controlling Interests stood at $115.3 million in 2022, then slumped by 102.8% to -$3.2 million in 2023, then soared by 497.27% to $12.8 million in 2024, then jumped by 208.64% to $39.6 million in 2025, then dropped by 0.14% to $39.5 million in 2026.
• According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered $39.5 million, $7.0 million, and $39.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.